An overview on the evaluated video retrieval tasks at TRECVID 2022

The TREC Video Retrieval Evaluation (TRECVID) is a TREC-style video analysis and retrieval evaluation with the goal of promoting progress in research and development of content-based exploitation and retrieval of information from digital video via open, tasks-based evaluation supported by metrology. Over the last twenty-one years this effort has yielded a better understanding of how systems can effectively accomplish such processing and how one can reliably benchmark their performance. TRECVID has been funded by NIST (National Institute of Standards and Technology) and other US government agencies. In addition, many organizations and individuals worldwide contribute significant time and effort. TRECVID 2022 planned for the following six tasks: Ad-hoc video search, Video to text captioning, Disaster scene description and indexing, Activity in extended videos, deep video understanding, and movie summarization. In total, 35 teams from various research organizations worldwide signed up to join the evaluation campaign this year. This paper introduces the tasks, datasets used, evaluation frameworks and metrics, as well as a high-level results overview.Comment: arXiv admin note: substantial text overlap with arXiv:2104.13473, arXiv:2009.0998

TRECVID 2018: Benchmarking Video Activity Detection, Video Captioning and Matching, Video Storytelling Linking and Video Search

International audienc

Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Abstract Background Primary cytoreductive surgery followed by adjuvant chemotherapy is the standard treatment for advanced epithelial ovarian cancer. The average interval between surgery and chemotherapy initiation is approximately 4-weeks at most centers; however, since surgery may accelerate residual tumor growth, a shorter interval may be more beneficial. Methods The murine ID8 cell model of ovarian cancer was used to examine the efficacy of cisplatin treatment administered perioperatively or 7 days after surgical wounding. Luciferase-expressing cells ID8 cells were injected intraperitoneally (i.p.) into female C57/Bl6 mice. Fourteen days post-injection, animals received an abdominal incision or anesthesia alone and received i.p. cisplatin either on the surgical day or 7 days later, or received no chemotherapy. Additional animals received cisplatin 28 days after wounding for comparison. Results Abdominal tumor mass increased 2.5-fold in wounded vs. unwounded animals as determined by bioluminescent in vivo tumor imaging. Cisplatin administered on the day of wounding decreased tumor burden by 50%, as compared to 90% in unwounded animals. Cisplatin on day 7 or day 28 decreased tumor burden by 80 and 37% respectively. Conclusions Surgical wounding increases ovarian tumor mass and decreases perioperative cisplatin efficacy in this animal model. Administration of cisplatin 1 week after surgery was more effective than cisplatin administered perioperatively or 4 weeks after surgery

Additional file 1: of Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Table S1. Luciferase activity levels of clonally selected ID8 cells stably transfected with PB-CAG-Luciferase-IRES-eGFP-pA vector. (DOCX 15 kb

TRECVID 2019: An evaluation campaign to benchmark Video Activity Detection, Video Captioning and Matching, and Video Search & retrieval

International audienc

Evaluating Multiple Video Understanding and Retrieval Tasks at TRECVID 2021

International audienc